| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.4M | — | -65.1% |
| SG&A Expense | $1.8M | — | -24.2% |
| Operating Income | -$3.3M | — | +50.0% |
| Pre-tax Income | -$3.2M | — | +50.3% |
| Income Tax | $3K | — | -35.8% |
| Net Income | -$3.2M | — | +50.3% |
| EPS (Basic) | -$0.46 | — | -253.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.2M | +53.7% | +319.5% |
| Current Assets | $23.6M | +56.0% | +276.5% |
| Total Assets | $23.6M | +48.0% | +232.9% |
| Current Liabilities | $6.1M | -15.9% | -46.8% |
| Total Liabilities | $6.1M | -15.9% | -47.0% |
| Stockholders' Equity | $17.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | +53.6% |
| Financing Cash Flow | $11.6M | — | — |
| +491.0% |